Home|Journals|Articles by Year|Audio Abstracts
 

Original Article



Evaluation of Acute and Sub-Acute toxicity Assessment of Marine Diatom Thalassiosira weissflogii

Ashashalini A, Syed Ali M, Anuradha V, Ravikumar S.




Abstract
Cited by 1 Articles

Several bioactive compounds from marine microalgae have demonstrated diverse biological activities with positive effects on human health. As new technologies are emerging for the study of bioactive compounds from natural sources, determination of their toxicity profile becomes inevitable. Diatoms are rich in minerals and secondary metabolites were reported as potent anti-cancer agents. The diatoms is potentially effective as a carrier for targeted drug delivery in cancer diseases. In vivo studies have shown no significant symptoms of tissue damage in animal models, suggesting the suitability of a diatoms extract of T.weissflogii. The diatomsÂ’ methanolic extract showed promising avenues for further preclinical studies in texploring their pharmacological potential. In future, these marine diatoms rich in cytotoxic compounds will be harnessed for the discovery of new lead compounds. The diatoms of Thalassiosira weissflogii could be further evaluated for their efficacy against cancer models to achieve targeted delivery and safe treatment.

Key words: Acute toxicity, Biocompatibility, Thalassiosira weissflogii, Sub acute toxicity, Histopathological examination.






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.